Glass with the Expert

Monday, November 4
16:00 -17:00 and 17:30-18:30

ESGO 2019 offers the opportunity to interact with the expert of your choice, to ask and to learn about their specialised field.

Reserve Your Place with the Expert

Check out the list of topics and experts below, and enroll for a topic of your choice as you register for ESGO 2019*.

Seating is limited and will be on a ‘first come first served’ basis.

Get a head start and Register for ESGO 2019!

* Option to enroll for a topic will be available soon

Round Tables I: 16:00-17:00

List of Topics

> Surgical staging of endometrial cancer

Nadeem Abu Rustum, USA


> First line Maintenance therapy in ovarian cancer

Susana Banerjee, UK


> Clinical consequences and limitation of tumor profiling in gynecological oncology

Ioana Braicu, Germany


 > New definitions-What is platinum resistant ovarian cancer?

Jonathan Ledermann, UK


> The role of PARP inhibitors in ovarian cancer

Mansoor Mirza, Denmark


> Molecular endometrial cancer classification

Sandro Pignata, Italy


> Sex cords tumors

Isabelle Ray-Coquard, France


> What is the best approach and schedule for ovarian cancer surgery?

Jalid Sehouli, Germany

Round Tables II: 17:30-18:30

List of Topics

>  The “Pelvic nodes issue” in endometrial cancer

Uzi Beller, Israel

> Molecular endometrial cancer classification

Tjallin Bosse, The Netherlands


 > International differences in practice, surgical philosophy and training

and the impact on the evolution of gyanecological oncology

Christina Fotopoulou, UK


> Hormonal management of patients with potentially hormone responsive recurrent / metastatic gynaecological cancers

Michael Friedlander, Australia


> Molecular biology and treatment of rare epithelial ovarian cancer sub-types:

low grade serous, endometrioid and clear cell

Charlie Gourley, UK


 > The role of PARP inhibitor in ovarian cancer treatment: the present and the future

Domenica Lorusso, Italy


> Immunotherapy in gynaecological oncology

Christian Marth, Austria


> Is it time for PARP inhibitor treatment in first-line for every patient with advanced ovarian cancer?

Eric Pujade-Lauraine, France


> Surgical approach to radical hysterectomy in patients with early cervical cancer

Pedro Ramirez, USA


> Indications and imaging prior to neoadjuvant chemotherapy in advanced ovarian cancer

Ignace Vergote, Belgium



* List of Topics and speakers as of July 3, 2019

You may also like


Reasons to Attend



Read More


Athens Landmarks



Read More

Porch of the Caryatids

Hotels in Athens



Read More



 Opens in January, 2019.


Read More